NCT04299581
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
Clinical trial condition
Intrahepatic Cholangiocarcinoma
Explore clinical trials studying Intrahepatic Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.
72 public trials
33 recruiting studies
Intrahepatic Cholangiocarcinoma trial results
Recruiting
TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma
NCT04954781
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT05010681
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT05557578
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- 1# Banshan East Rd. Zhejiang cancer hospital Hangzhou, Zhejiang, China
- Jia Wu Hanzhou, Zhejiang, China
NCT06664021
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- No.2 People's Hospital of Fuyang city Fuyang, Anhui, China
- Anhui province hospital Hefei, Anhui, China
NCT06160752
- Conditions
- Acrocephalosyndactylia, Adenocarcinoma, Bone Diseases, +24 more
- Locations
-
- University of California San Francisco (UCSF) San Francisco, California, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- The Ohio State University Columbus, Ohio, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Mayo Clinic Florida Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
Recruiting
GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC
NCT06505486
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, China
NCT06298968
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
NCT06296563
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Shandong Cancer Hospital and Institute Jinan, Shandong, China